Tag: ZAGENO

ZAGENO Forms a Strategic Partnership With Hatch.Bio Labs, a Premier Biotech Incubator

Biotech startups often encounter administrative roadblocks on their path to achieving breakthroughs in life sciences. Today, ZAGENO, the leading AI-powered marketplace for lab supplies, and Hatch.Bio Labs, a premier biotech incubator, join forces to eliminate these challenges.

ZAGENO x Hatch.Bio Labs
ZAGENO and Hatch.Bio Labs Partner to Streamline Lab Operations

This strategic partnership empowers Hatch.Bio residents with a streamlined lab supply procurement process, allowing them to prioritize groundbreaking research. ZAGENO’s platform offers an Amazon-like shopping experience for lab supplies, featuring:

Effortless Management: Discounted rates, easy price comparison of 5,300+ suppliers, single bill-to options, and automated order tracking.

Dedicated Support: Fast onboarding, procurement best practices, and frequent on-site guidance to maximize platform value.

Reduced Costs: Exclusive discounts for Hatch members, with free access for smaller startups.

“Biotech startups are at the forefront of innovation, but administrative hurdles can delay their progress,” says Florian Wegener, CEO and Founder of ZAGENO. “Our partnership with Hatch.Bio simplifies lab supply ordering for their members, saving them valuable time and resources.”

James Weis, Hatch.Bio CEO, adds, “This collaboration provides our residents with a critical operational advantage, allowing them to streamline operations and accelerate research.”

Through this partnership, Hatch.Bio tenants will gain seamless access to ZAGENO’s AI-powered lab supply marketplace. By integrating ZAGENO’s platform with Hatch.Bio’s facilities and support, this collaboration simplifies procurement, automates tracking, and minimizes administrative tasks, freeing researchers to focus on advancing their research to the clinic.

About ZAGENO
ZAGENO is transforming lab supply procurement with the industry’s largest AI-powered marketplace, featuring over 40 million products from 5,300+ global suppliers. Scientists, lab managers, and procurement teams rely on ZAGENO’s all-in-one platform for painless lab supply procurement that optimizes budgets and enhances productivity. With automated order and delivery tracking, custom workflows, real-time spend analytics, and offloaded supplier management, ZAGENO empowers labs of all sizes to achieve full lab supply ordering automation. Explore ZAGENO’s marketplace and discover how it can streamline your lab supply procurement: www.zageno.com or request access at bit.ly/HatchBio-Labs.

About Hatch.Bio Labs
Hatch.Bio Labs is the premier biotechnology and life sciences incubation platform dedicated to reducing operational barriers for biotechnology and life sciences companies. We provide best-in-class, highly flexible, and cost-effective laboratory and office facilities, natively integrated with comprehensive scientific and operational support and strategic partnerships within a modern technology stack-all to help our resident companies grow more rapidly and efficiently. Our mission is to empower biotech pioneers to develop transformative technologies and advance the pace of biotechnology innovation. For more information and to inquire about becoming a tenant, visit www.hatch.bio.

Contact Information
Stephanie Harold
pr@zageno.com
+1 (857) 477-8479

SOURCE: ZAGENO

Related Images

Biotech Startups Get a Boost: ZAGENO and Hatch.Bio Labs Partner to Streamline Lab Operations

ZAGENO Recognized as a Trailblazer in the ProcureTech100 2023 Awards for its Revolutionary Marketplace

ZAGENO Inc., the leading marketplace for life science research products, proudly announces its inclusion in the prestigious 2023 ProcureTech100. This distinguished reward is reserved for a select group of technology, data, and analytics solutions celebrated for their exceptional innovation, scalability, and transformative impact on the digital procurement landscape.

Florian Wegener, CEO of ZAGENO Inc., expressed honor in being recognized among this elite group of companies, stating, “We look forward to advancing our mission to accelerate life science research and empower procurement teams globally.”

The rigorous selection process scrutinized over 5,000 global digital solutions, evaluated by esteemed procurement leaders, technology experts, and B2B investors. Dr. Elouise Epstein, Partner at Kearney, highlighted the significance of ProcureTech100 in identifying groundbreaking solutions that drive short-term benefits and long-term value in the supply chain.

ZAGENO, the leading lab supply marketplace, provides a superior selection of high-quality products from leading suppliers, emphasizing quality and convenience. Through streamlined order tracking and billing, ZAGENO simplifies and enhances the global procurement process for biotech and pharmaceutical companies. Customers benefit from the following:

1. Accelerate “Phase I Clinical Trial” Timelines: ZAGENO is committed to minimizing the time it takes to reach “phase I clinical trials,” ensuring a swift and efficient progression through crucial research phases.
2. Enhance Scientist Productivity: By leveraging ZAGENO’s platform, scientists can experience increased efficiency and productivity, streamlining their workflow and allowing them to focus on advancing critical research initiatives.
3. Strengthen Supply Chain Resilience: ZAGENO is pivotal in strengthening the supply chain’s resilience for biotech and pharma companies, offering a dependable and robust procurement infrastructure that contributes to overall supply chain stability.

The announcement of the 2023 ProcureTech100 took place at the ProcureTech PIONEERS event, attracting hundreds of procurement and digital leaders. ZAGENO is honored to be featured in this exclusive list and remains committed to delivering optimal solutions for its customers.

To learn more about ProcureTech100, please visit the ProcureTech100 website.

To learn more about ZAGENO Inc., please visit the ZAGENO website.

Contact Information:
Stephanie Harold
pr@zageno.com 
+1 (857) 477-8479

ZAGENO Empowers Life Science Research with Unparalleled Efficiency and Cost Savings

ZAGENO, the leading online marketplace for life science research products, announces the completion of a $33 million funding round. General Catalyst, the largest public pension fund in the United States, Grazia Equity, OakRidge Management Group, and a German investment house led this round, joined by existing investors Capnamic Ventures and HighSage Ventures.

This funding propels ZAGENO’s expansion in the United States and Europe, significantly enhancing the accessibility and affordability of life science research products. ZAGENO simplifies product discovery, experiment planning, and seamless purchasing from thousands of suppliers. The marketplace revolutionizes the scientific workflow, saving time and product costs. With a wide selection of quality products and verified suppliers, scientists benefit from competitive pricing fostered by the marketplace’s transparency and supplier choice.

“We’re thrilled to welcome new investors, including one of America’s most powerful shareholder bodies and global leader in the investment industry and a prominent German investment house, while enjoying continued support from General Catalyst and existing investors,” said Florian Wegener, CEO of ZAGENO. “This funding empowers scientists to focus on scientific value creation.”

ZAGENO’s online marketplace offers a vast selection of products and services, including laboratory equipment, consumables, chemicals, antibodies, and customized solutions. By providing scientists access to a network of verified suppliers, the ZAGENO platform enables informed purchasing decisions.

“ZAGENO is transforming the scientific research industry with its groundbreaking platform,” said Larry Bohn, Managing Partner at General Catalyst. “We proudly support their journey.”

“With this funding, ZAGENO is positioned to deliver even greater value to scientists worldwide,” emphasized Joe von Rickenbach, Chairman of the Board of ZAGENO. “Their innovative platform drives unmatched efficiency and cost savings.”

ZAGENO is primed for rapid growth and pioneering innovation in the scientific research industry with this new funding.

To learn more about ZAGENO, please visit www.zageno.com.

About ZAGENO
ZAGENO is a marketplace for life science research products. By revolutionizing how scientists discover, procure, and manage life science research products, ZAGENO supports researchers pursuing breakthroughs that improve our lives. With an extensive catalog, advanced search functionality, transparent pricing, and dedicated customer support, ZAGENO simplifies the research workflow and enables scientists to focus on groundbreaking discoveries. ZAGENO is a global company with offices in Cambridge, San Francisco, Berlin, and Bangalore. For more information, visit www.zageno.com.

About General Catalyst
General Catalyst is a venture capital firm that invests in powerful, positive change that endures – for our entrepreneurs, our investors, our people, and society. We support founders with a long-term view who challenge the status quo, partnering with them from seed to growth stage and beyond to build companies that withstand the test of time. With offices in San Francisco, Palo Alto, New York City, London, and Boston, the firm has helped support the growth of businesses such as: Airbnb, Deliveroo, Guild, Gusto, Hubspot, Illumio, Lemonade, Livongo, Oscar, Samsara, Snap, Stripe, and Warby Parker. For more: www.generalcatalyst.com.

Contact Information
Stephanie Harold
pr@zageno.com
+1 (857) 477-8479